Healthcare Industry News: CollaGenex Pharmaceuticals
News Release - April 10, 2012
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
New Senior Management Team also includes CFO Mike KuczaOCEANSIDE, N.Y., April 10, 2012 -- (Healthcare Sales & Marketing Network) -- Ellman International, Inc. announced the appointment of Dave Pfeiffer to the position of Executive Vice President and Chief Commercial Officer. Mr. Pfeiffer will be responsible for all domestic & international commercial activities. Mr. Pfeiffer, previously a member of the Board of Directors of Ellman International, will report to Frank D'Amelio, CEO of Ellman. Also continuing as part of the Senior Management team is Mike Kucza, Chief Financial Officer. Ellman is a leading provider of radiofrequency (RF) generators used for surgical applications and aesthetic procedures such as the non-invasive skin tightening procedure known as Pelleve.
"Dave is a seasoned professional specializing in launch and commercialization of new products in the health care arena," said Frank D'Amelio, CEO of Ellman International, Inc. "He has spent the last 10 years working primarily in the dermatology field running both the sales and marketing functions. He also has experience in business and product development. Dave has a strong understanding of all the exciting opportunities and growth options at Ellman from his two years as a member of the Board of Directors. I look forward to working with Dave to integrate all of the commercial functions at Ellman."
"I also want to note that Mike Kucza, who has been with Ellman for approximately 2 years, will continue as an important member of the senior management team. Mike has proven himself to be not only a strong accounting manager but also a strategic executive who helps to prioritize key commercial and product development activities. I am fortunate to have the support a world class senior management team that along with Dave and Mike includes Kirsten Doerfert, Sr. VP of Global Marketing; Gary Wilson, Sr. VP of International Sales; and Dennis Herman, Sr. VP, US Sales."
Dave Pfeiffer was most recently Chief Operating Officer at NB Therapeutics, a venture capital backed company developing treatments for onychomycosis, or toenail fungus. Prior to that, he was at CollaGenex Pharmaceuticals, where his last position was as Sr. VP, Sales and Marketing. Dave helped launch Oracea, a rosacea treatment with sales of over $250 million annually. Galderma, Inc., a privately owned dermatology company, purchased CollaGenex in 2008. Dave spent his career prior to CollaGenex in various sales and marketing positions at SmithKline Beecham, Zeneca and Lederle Laboratories.
Mike Kucza worked at Deloitte & Touche LLP as both an auditor and consultant. He was first introduced to private equity as the audit manager on the firm's largest customer, Kohlberg, Kravits, Roberts & Co. Mike left D&T to become the controller and eventually CFO of a Swedish owned venture capital management company. In 2002, Mike moved to the portfolio company side of private equity when joining InfoHighway Communications, a GTCR owned telecommunications company. Serving as their CFO for four years, InfoHighway was sold above book value after the investment was written off by GTCR during the collapse of the telecommunications industry. In 2006, Mike and members of his InfoHighway management team started a privately held distribution business before he joined Ellman in 2010.
About Ellman International, Inc.
Ellman International is a manufacturer of surgical devices and non-invasive aesthetic devices used to perform medical, aesthetic, dental and veterinary procedures in the United States, Europe, Latin America and Asia. Ellman's product portfolio enables medical professionals to perform surgical procedures that produce less tissue damage, scarring and pain than the competition. The company is a leader in the use of radiofrequency generators for surgical and non-invasive aesthetic procedures, including Pelleve, a patented, painless procedure for skin tightening. Pelleve precisely delivers energy to the dermal tissue using advanced radiofrequency technology to induce collagen contraction without damaging the epidermis. The result is skin tightening and contouring with a noticeable improvement in skin quality and texture. Ellman is primarily owned by Baird Capital Partners, Chicago, IL. For more information, visit www.ellman.com, www.pelleve.com and www.ellumine.com.
Source: Ellman International
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
